journal article·2017-05

Programmed Multiresponsive Vesicles for Enhanced Tumor Penetration and Combination Therapy of Triple‐Negative Breast Cancer

Fangyuan Zhou, Bing Feng, Tingting Wang, Dangge Wang, Qingshuo Meng, Jianfeng Zeng, Zhiwen Zhang, Siling Wang, Haijun Yu, Yaping Li

Advanced Functional Materials· Volume 27· Issue 20
Publisher page

Abstract

Nanomedicine is a promising approach for combination chemotherapy of triple‐negative breast cancer (TNBC). However, the therapeutic efficacy of nanoparticulate drugs is suppressed by a series of biological barriers. The authors herein present a programmed stimuli‐responsive liposomal vesicle to overcome the sequential barriers for enhanced TNBC therapy. The intelligent vesicles are engineered by integrating an enzyme‐cleavable polyethylene glycol (PEG) corona, a light‐responsive photosensitizer pheophorbide a (PPa), and a temperature‐sensitive liposome (TSL) into a single nanoplatform. The resultant enzyme, light, and temperature multisensitive liposome (ELTSL) is sequentially coloaded with a lipophilic oxaliplatin prodrug of hexadecyl‐oxaliplatin carboxylic acid (HOC) and hydrophilic doxorubicin hydrochloride (DOX). Dual drug‐loaded ELTSL displays enhanced tumor penetration and increased cellular uptake upon matrix metalloproteinase 2 mediated cleavage of the PEG corona. Under NIR laser irradiation, PPa induces mild hyperthermia effect to trigger ultrafast drug release in the tumor cells. In combination with PPa‐mediated photodynamic therapy, HOC and DOX coloaded ELTSL show significantly improved antitumor efficacy than monotherapy. Given the clinically translatable potential of the liposomal vesicles, ELTSL might represent a promising nanoplatform for combination TNBC therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Drug Research & Center of Pharmaceutics Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai 201203 China

School of Pharmacy Shenyang Pharmaceutical University Shenyang 110016 China

School for Radiological and Interdisciplinary Sciences (RAD‐X) Soochow University Suzhou 215123 China

Funding

National Natural Science Foundation of China · Chinese Academy of Sciences · Youth Innovation Promotion Association of the Chinese Academy of Sciences

References (59)

Show source-provided references
1. 10.1016/j.cell.2015.08.06310.1016/j.cell.2015.08.063 ↗
2. Crunkhorn S. · Nat. Rev. Drug Discovery · 2016 · 15 · 532
3. Keane T. E. · Cancer Res. · 1994 · 54 · 475
4. 10.1038/nbt0206-16310.1038/nbt0206-163 ↗
5. 10.1021/nn401079610.1021/nn4010796 ↗
6. 10.1038/nbt.154910.1038/nbt.1549 ↗
7. 10.1016/j.addr.2009.05.00610.1016/j.addr.2009.05.006 ↗
8. 10.1021/mp200243k10.1021/mp200243k ↗
9. 10.1016/j.addr.2015.10.01910.1016/j.addr.2015.10.019 ↗
10. 10.1021/mp400610b10.1021/mp400610b ↗
11. Straubinger R. M. · Cancer Res. · 1988 · 48 · 5237
12. 10.1016/j.biomaterials.2015.09.02210.1016/j.biomaterials.2015.09.022 ↗
13. 10.1073/pnas.101136810710.1073/pnas.1011368107 ↗
14. 10.1073/pnas.85.18.694910.1073/pnas.85.18.6949 ↗
15. 10.1200/JCO.2001.19.5.144410.1200/JCO.2001.19.5.1444 ↗
16. 10.1038/ncomms528010.1038/ncomms5280 ↗
17. 10.1021/nn201390410.1021/nn2013904 ↗
18. 10.1016/j.jconrel.2012.03.02010.1016/j.jconrel.2012.03.020 ↗
19. 10.1517/1354378090311416810.1517/13543780903114168 ↗
20. 10.1021/nn302148p10.1021/nn302148p ↗
21. 10.1038/nbt.333010.1038/nbt.3330 ↗
22. 10.1073/pnas.152208011310.1073/pnas.1522080113 ↗
23. 10.1002/anie.20120772110.1002/anie.201207721 ↗
24. 10.1021/nl103373310.1021/nl1033733 ↗
25. 10.1021/nn205023w10.1021/nn205023w ↗
26. 10.1158/1078-0432.CCR-03-003510.1158/1078-0432.CCR-03-0035 ↗
27. Kneidl B. · Int. J. Nanomed. · 2014 · 9 · 4387
28. Needham D. · Cancer Res. · 2000 · 60 · 1197
29. 10.1016/j.biomaterials.2012.03.01810.1016/j.biomaterials.2012.03.018 ↗
30. 10.1021/acs.chemrev.5b0057810.1021/acs.chemrev.5b00578 ↗
31. 10.1016/j.jconrel.2010.01.00610.1016/j.jconrel.2010.01.006 ↗
32. 10.1016/j.jconrel.2013.03.01110.1016/j.jconrel.2013.03.011 ↗
33. 10.1007/s11095-010-0154-210.1007/s11095-010-0154-2 ↗
34. 10.1016/j.jconrel.2010.03.01610.1016/j.jconrel.2010.03.016 ↗
35. 10.1021/nn101937h10.1021/nn101937h ↗
36. 10.1021/nn300524f10.1021/nn300524f ↗
37. 10.1021/cr900236h10.1021/cr900236h ↗
38. 10.1021/acs.nanolett.6b0199410.1021/acs.nanolett.6b01994 ↗
39. 10.1007/s10549-009-0654-010.1007/s10549-009-0654-0 ↗
40. 10.1016/j.ccr.2005.05.02410.1016/j.ccr.2005.05.024 ↗
41. 10.1016/S0927-7765(99)00156-310.1016/S0927-7765(99)00156-3 ↗
42. 10.1038/nrd103310.1038/nrd1033 ↗
43. 10.1002/adfm.20120221510.1002/adfm.201202215 ↗
44. 10.1016/j.ygyno.2005.08.02010.1016/j.ygyno.2005.08.020 ↗
45. 10.1200/JCO.1989.7.5.57210.1200/JCO.1989.7.5.572 ↗
46. 10.1200/JCO.2003.02.50510.1200/JCO.2003.02.505 ↗
47. 10.1002/adfm.20160296310.1002/adfm.201602963 ↗
48. 10.7150/thno.1351510.7150/thno.13515 ↗
49. 10.1073/pnas.130395811010.1073/pnas.1303958110 ↗
50. 10.1016/j.biomaterials.2012.05.04910.1016/j.biomaterials.2012.05.049 ↗
51. 10.1038/nrm185810.1038/nrm1858 ↗
52. 10.1002/ijc.2943010.1002/ijc.29430 ↗
53. 10.1093/jnci/djk00510.1093/jnci/djk005 ↗
54. 10.1038/ncomms571210.1038/ncomms5712 ↗
55. 10.1021/nl504537810.1021/nl5045378 ↗
56. 10.1158/1078-0432.CCR-06-244310.1158/1078-0432.CCR-06-2443 ↗
57. 10.1038/ncomms900310.1038/ncomms9003 ↗
58. 10.1002/adfm.20160170310.1002/adfm.201601703 ↗
59. 10.1016/j.biomaterials.2015.06.01710.1016/j.biomaterials.2015.06.017 ↗